Collegium Pharmaceutical financial statements
콜레지움 파머슈티컬NASDAQ:COLL · Nasdaq · Healthcare · sector #16$21.88+0.05%
2026-10-06 close · prelimCollegium Pharmaceutical's published financial data is dated 2026-10-04. 2024 revenue was $631M. 2024 operating profit was $159M.
Reported results
Quantus Signal · live data · not investment advice · Privacy Policy